Deployment: 359Passenger Status:PublicPassengerChecking status…
The Modern Living Peace Train™. How everything connects. FOLLOW, THE ORANGE. A train travels through a living landscape at sunrise.
FOLLOW, THE ORANGE!Search the publication

The Modern LivingPeace Train™

REAL CONNECTIONS.
A HEALTHIER TOMORROW.

SEE HOW EVERYTHING CONNECTS.

Investigating how our choices shape people, places
and the living systems we all depend on.

THE ENERGY OF LIVING · CONNECTED CONDITION JOURNEY

The Energy of Living →

The Modern Living Fountain of Youth™A new discovery begins

The Modern Living Fountain of Youth™ — Original creative concept and direction by the Founder of The Modern Living Peace Train™.

Graves disease: when an immune signal stimulates the thyroid

Graves disease · Food, normal function and supported decisions

Conceptual antibody signal directed toward a simplified thyroid gland, with hormone symbols to its right. Symbols do not encode measured hormone levels or tissue damage.
Conceptual illustrationIn Graves disease, thyroid-stimulating antibodies can cause the gland to produce excess thyroid hormone. This signaling concept does not depict a blood-test result or an individual’s disease severity.Illustration context: niddk.nih.gov ↗
  1. Thyroid-stimulating antibody symbol
  2. Thyroid gland
  3. Thyroid hormone symbols

Graves disease is an autoimmune cause of an overactive thyroid, rather than another name for every case of hyperthyroidism. This journey follows the immune signal and its consequences, leaving room for your own experience and questions. [ATA-GRAVES] [TESTS]

Explore the Energy Anatomy connections.

These associations belong to the publication’s Energy Anatomy framework; they are not treatments or evidence of a food effect.

Primary connection: Throat →

Sources and review scope

These source notes explain the evidence consulted and its limits. Educational information does not replace individual medical care.

ATA-GRAVES
American Thyroid Association: Graves’ Disease

What causes Graves’ disease?; Symptoms (eye disease); Diagnosis; Treatment · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: No page revision date captured. Targeted sections checked on 11 November 2026 (UTC). Targeted educational text; underlying trials, comparative outcomes and complete prescribing evidence have not been comprehensively appraised.

NHS-OVERVIEW
NHS: Overactive thyroid — overview

Definition; symptoms; treatment; causes · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: Reviewed 11 April 2023; review due 11 April 2026. Targeted sections checked on 11 November 2026 (UTC). Targeted educational text; underlying trials, comparative outcomes and complete prescribing evidence have not been comprehensively appraised.

CRISIS-HIGH
NHS: Overactive thyroid — complications

Eye problems; pregnancy; thyroid storm · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: Reviewed 11 April 2023; review due 11 April 2026. Targeted sections checked on 11 November 2026 (UTC). Displayed review date is past due; targeted content remains accessible. This is not a fresh NHS review or a complete clinical appraisal.

CARB
NHS: Side effects of carbimazole

Serious side effects; Serious allergic reaction; other side effects · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: Reviewed 1 May 2025; next review 1 May 2028. Targeted sections checked on 11 November 2026 (UTC). Targeted educational text; underlying trials, comparative outcomes and complete prescribing evidence have not been comprehensively appraised.

EYES
NHS: Bulging eyes

Immediate action required; treatment · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: Reviewed 26 June 2026; next review 26 June 2029. Targeted sections checked on 11 November 2026 (UTC). Targeted educational text; underlying trials, comparative outcomes and complete prescribing evidence have not been comprehensively appraised.

TESTS
NIDDK: Thyroid Tests

TSH and T4 tests; thyroid antibody tests · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: Last reviewed May 2017. Targeted sections checked on 11 November 2026 (UTC). Targeted educational text; underlying trials, comparative outcomes and complete prescribing evidence have not been comprehensively appraised.

GRAVES
NIDDK Graves Disease

Definition L 147–148; eye mechanism/function L 188–196; cause/TSI L 202–203; diagnosis L 206–211; antithyroid warning L 243–252; iodine L 295–300; footer L 325 · Retained targeted NIDDK source reading from 2 November 2026; not a completed current-source or clinical appraisal.

Selected NIDDK supporting passages were read on 2 November 2026; no new source-currency or clinical appraisal of that page is claimed. Product-specific urgent instructions take priority.

ATA-HASH
American Thyroid Association: Hashimoto’s Thyroiditis

Definition; symptoms; diagnosis; treatment with normal or low thyroid function · Supporting educational text checked in the cited sections. Independent clinical review has not yet been completed.

Publisher date: No page revision date captured. Targeted sections checked on 11 November 2026 (UTC). Targeted educational text; underlying trials, comparative outcomes and complete prescribing evidence have not been comprehensively appraised.

NHS-TREATMENT
NHS: Overactive thyroid — treatment

Medicine, lines 24–33; treatment options and specialist care, lines 15–23. General side-effect wording on this older page does not supersede the medicine-specific urgent carbimazole instructions. · Targeted treatment sections read; independent clinical review has not been completed.

The displayed review date is past due. Targeted treatment text was read on 11 November 2026 (UTC), not freshly reviewed by NHS. Product-specific urgent instructions remain controlling. No efficacy percentage, personal course, dose or treatment selection is proposed.

The journey continues beneath the surface.

Continue to explore the signals, the evidence and the questions you want to bring to daily life.

Continue as a Passenger →